S. Velu

971 total citations
30 papers, 685 citations indexed

About

S. Velu is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, S. Velu has authored 30 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 23 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in S. Velu's work include Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (16 papers) and Infectious Diseases and Tuberculosis (13 papers). S. Velu is often cited by papers focused on Tuberculosis Research and Epidemiology (24 papers), Mycobacterium research and diagnosis (16 papers) and Infectious Diseases and Tuberculosis (13 papers). S. Velu collaborates with scholars based in India, United Kingdom and China. S. Velu's co-authors include C. V. Ramakrishnan, S. Devadatta, Wallace Fox, S. Radhakrishna, Rebecca Andrews, J.B. Selkon, H Stott, P. R. Somasundaram, P R Gangadharam and B. Janardhanam and has published in prestigious journals such as Journal of Hazardous Materials, Thrombosis Research and IEEE Journal of Biomedical and Health Informatics.

In The Last Decade

S. Velu

28 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Velu India 15 479 327 214 82 60 30 685
S. Devadatta India 16 503 1.1× 329 1.0× 215 1.0× 101 1.2× 64 1.1× 33 726
H Stott United Kingdom 16 423 0.9× 288 0.9× 180 0.8× 47 0.6× 25 0.4× 42 681
Ruth Tall United Kingdom 12 210 0.4× 262 0.8× 100 0.5× 58 0.7× 42 0.7× 22 506
Yew Ww China 9 411 0.9× 369 1.1× 121 0.6× 74 0.9× 40 0.7× 21 561
Hanneke M. J. Nijland Netherlands 6 505 1.1× 368 1.1× 173 0.8× 63 0.8× 72 1.2× 7 660
B. Janardhanam India 8 232 0.5× 175 0.5× 86 0.4× 21 0.3× 93 1.6× 9 335
Takao Yamazaki Japan 13 331 0.7× 261 0.8× 53 0.2× 83 1.0× 40 0.7× 23 541
Jennifer L. Stotka United States 11 188 0.4× 272 0.8× 46 0.2× 123 1.5× 135 2.3× 17 756
Genevieve H. Wills United Kingdom 6 597 1.2× 402 1.2× 191 0.9× 151 1.8× 54 0.9× 8 742
Chi‐Chiu Leung China 18 618 1.3× 476 1.5× 242 1.1× 63 0.8× 159 2.6× 29 904

Countries citing papers authored by S. Velu

Since Specialization
Citations

This map shows the geographic impact of S. Velu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Velu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Velu more than expected).

Fields of papers citing papers by S. Velu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Velu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Velu. The network helps show where S. Velu may publish in the future.

Co-authorship network of co-authors of S. Velu

This figure shows the co-authorship network connecting the top 25 collaborators of S. Velu. A scholar is included among the top collaborators of S. Velu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Velu. S. Velu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velu, S., Shruti Pandita, Neha S. Joshi, et al.. (2025). Lead exposure during development alters synaptic organization and protein expression in rat hippocampus. Journal of Hazardous Materials. 500. 140582–140582.
2.
Velu, S., et al.. (2024). Neural Networks Based Smart E-Health Application for the Prediction of Tuberculosis Using Serverless Computing. IEEE Journal of Biomedical and Health Informatics. 28(9). 5043–5054. 7 indexed citations
3.
Blann, Andrew D., et al.. (2012). Renal function and aspirin resistance in patients with coronary artery disease. Thrombosis Research. 130(3). e103–e106. 10 indexed citations
4.
Devadatta, S., John Dawson, Wallace Fox, et al.. (1970). Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone.. PubMed. 42(3). 337–51. 35 indexed citations
5.
Devadatta, S., N.K. Menon, S. Radhakrishna, et al.. (1970). A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis. Tubercle. 51(3). 263–269. 4 indexed citations
8.
Ramakrishnan, C. V., S. Devadatta, S R Kamat, et al.. (1967). Cycloserine plus ethionamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy. Tubercle. 48(2). 114–127. 5 indexed citations
9.
Devadatta, S., S. Radhakrishna, C. V. Ramakrishnan, et al.. (1966). A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.. PubMed. 34(4). 533–51. 56 indexed citations
11.
Ramakrishnan, C. V., Ankit Bhatia, S. Devadatta, et al.. (1962). The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.. PubMed. 26. 1–18. 7 indexed citations
13.
Selkon, J.B., Wallace Fox, P R Gangadharam, et al.. (1961). Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.. PubMed. 25. 779–92. 19 indexed citations
14.
Ramakrishnan, C. V., Rebecca Andrews, S. Devadatta, et al.. (1961). Influence of segregation to tuberculous patients for one year on the attack rate of tuberculosis in a 2-year period in close family contacts in South India.. PubMed. 24. 129–48. 21 indexed citations
15.
Ramakrishnan, C. V., Rebecca Andrews, S. Devadatta, et al.. (1961). Prevalence and early attack rate of tuberculosis among close family contacts of tuberculous patients in South India under domiciliary treatment with isoniazid plus PAS or isoniazid alone.. PubMed. 26. 361–407. 11 indexed citations
16.
Velu, S., Rebecca Andrews, J H Angel, et al.. (1961). Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate.. PubMed. 25. 409–29. 15 indexed citations
17.
Devadatta, S., Ankit Bhatia, Rebecca Andrews, et al.. (1961). Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.. PubMed. 25. 807–29. 24 indexed citations
18.
Velu, S., Rebecca Andrews, J H Angel, et al.. (1961). Streptomycin plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli, following previous chemotherapy. Tubercle. 42(2). 136–147. 22 indexed citations
19.
Devadatta, S., P R Gangadharam, Rebecca Andrews, et al.. (1960). Peripheral neuritis due to isoniazid.. PubMed. 23. 587–98. 120 indexed citations
20.
Devadatta, S., Rebecca Andrews, S. Radhakrishna, et al.. (1960). Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.. PubMed. 23. 149–33. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026